| Record Information |
| Version |
3.5 |
| Creation Date |
2009-07-24 18:02:47 -0600 |
| Update Date |
2013-02-08 17:29:18 -0700 |
| HMDB ID |
HMDB12552 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
12-Oxo-20-hydroxy-leukotriene B4 |
| Description |
12-oxo-20-hydroxy-leukotriene B4 is the metabolite of lipid omega-oxidation of leukotriene B4 (LTB4). LTB4 is the major metabolite in neutrophil polymorphonuclear leukocytes. Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. Leukotrienes are metabolites of arachidonic acid derived from the action of 5-LO (5-lipoxygenase). The immediate product of 5-LO is LTA4 (leukotriene A4), which is enzymatically converted into either LTB4 (leukotriene B4) by LTA4 hydrolase or LTC4 (leukotriene C4) by LTC4 synthase. The regulation of leukotriene production occurs at various levels, including expression of 5-LO, translocation of 5-LO to the perinuclear region and phosphorylation to either enhance or inhibit the activity of 5-LO. Biologically active LTB4 is metabolized by w-oxidation carried out by specific cytochrome P450s (CYP4F) followed by beta-oxidation from the w-carboxy position and after CoA ester formation. (PMID: 7649996 , 17623009 , 2853166 , 6088485 ). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs) and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes) and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signaling pathways. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (5S,20)-dihydroxy-12-keto-(6Z,8E,10E,14Z)-eicosatetraenoate
- (5S,20)-dihydroxy-12-keto-(6Z,8E,10E,14Z)-eicosatetraenoic acid
- (5S,20)-dihydroxy-12-oxo-(6Z,8E,10E,14Z)-eicosatetraenoate
- (5S,20)-dihydroxy-12-oxo-(6Z,8E,10E,14Z)-eicosatetraenoic acid
- 12-Keto-20-hydroxy-leukotriene B(,4)
- Ox20HLTB4
|
| Chemical Formula |
C20H30O5 |
| Average Molecular Weight |
350.4492 |
| Monoisotopic Molecular Weight |
350.20932407 |
| IUPAC Name |
(5R,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid |
| Traditional IUPAC Name |
(5R,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid |
| CAS Registry Number |
Not Available |
| SMILES |
OCCCCC\C=C/CC(=O)\C=C\C=C\C=C/[C@H](O)CCCC(O)=O |
| InChI Identifier |
InChI=1S/C20H30O5/c21-17-10-6-2-1-3-7-12-18(22)13-8-4-5-9-14-19(23)15-11-16-20(24)25/h3-5,7-9,13-14,19,21,23H,1-2,6,10-12,15-17H2,(H,24,25)/b5-4+,7-3-,13-8+,14-9-/t19-/m0/s1 |
| InChI Key |
CZWPUWRHQBAXJS-PABROBRYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Lipids |
| Class |
Eicosanoids |
| Sub Class |
Other Hydroxyeicosapolyenoic Acids |
| Other Descriptors |
- Aliphatic Acyclic Compounds
- Keto Fatty Acids
- Organic Compounds
- Straight Chain Fatty Acids
- Unsaturated Fatty Acids
|
| Substituents |
- Acryloyl Group
- Acyclic Alkene
- Allyl Alcohol
- Carboxylic Acid Salt
- Enone
- Fatty Alcohol
- Ketone
- Primary Alcohol
- Secondary Alcohol
|
| Direct Parent |
Other Hydroxyeicosapolyenoic Acids |
| Ontology |
| Status |
Expected and Not Quantified |
| Origin |
|
| Biofunction |
- Cell signaling
- Fuel and energy storage
- Fuel or energy source
- Membrane integrity/stability
|
| Application |
- Nutrients
- Stabilizers
- Surfactants and Emulsifiers
|
| Cellular locations |
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
Not Available |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
Not Available |
Not Available |
| LogP |
Not Available |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
|
| Biofluid Locations |
Not Available
|
| Tissue Location |
Not Available
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
Not Available |
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB029119 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
Not Available |
| KEGG Compound ID |
Not Available |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Not Available |
| NuGOwiki Link |
HMDB12552  |
| Metagene Link |
HMDB12552  |
| METLIN ID |
Not Available |
| PubChem Compound |
53481459  |
| PDB ID |
Not Available |
| ChEBI ID |
Not Available |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Not Available
|
| General References |
Not Available
|